REGENERON PHARMACEUTICALS, INC. Net Rentable Area
REGENERON PHARMACEUTICALS, INC. (REGN) had Net Rentable Area of 300.00 thousand sqft as of 2016-12-31, per its 10-K filed 2017-02-09.
Discontinued › Notes
us-gaap:NetRentableArea · last filed 2017-02-09
- 2016-12-31: Net Rentable Area 300.00K sqft.
| Period end | Net Rentable Area |
|---|---|
| 2016-12-31 | 300.00K sqft 10-K · filed 2017-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |